Invention Application
- Patent Title: PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTITUMOR EFFECT BY IMMUNE CHECKPOINT INHIBITOR
-
Application No.: US17682413Application Date: 2022-02-28
-
Publication No.: US20220249417A1Publication Date: 2022-08-11
- Inventor: Tohru Tanaka , Hidenori Ito , Ko Rii
- Applicant: SBI Pharmaceuticals Co., Ltd. , National Center for Child Health and Development
- Applicant Address: JP Tokyo; JP Tokyo
- Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee Address: JP Tokyo; JP Tokyo
- Priority: JP2017-231449 20171201
- Main IPC: A61K31/197
- IPC: A61K31/197 ; A61K33/26 ; C07K16/28 ; A61K33/24
Abstract:
The object of the invention is to provide a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor. Provided is a pharmaceutical composition for enhancing the antitumor effect by an immune checkpoint inhibitor comprising 5-aminolevulinic acids (ALAs) as the active ingredient.
Information query
IPC分类:
